GeoNova Capital, a UAE-based investment firm, commits $10 million as lead and cornerstone investor in NovaGen Group's proposed merger with Nasdaq-listed Veea Inc. The deal aims to create NovaGen Health Networks, a Nasdaq-listed platform combining AI and regenerative medicine. GeoNova also acts as corporate adviser and is inviting co-investors. The transaction awaits final documentation and approvals, while GeoNova seeks similar future public-market opportunities in biotech, AI, and other sectors.
GeoNova Capital's $10 million cornerstone investment in NovaGen is notable context for readers following biotech and health innovation. For readers following the health sector, here is Pluang's market snapshot as of Sep 18, 2026 01:31 WIB: Among 91 priced US health stocks, 66 rose and 25 fell. Notable movers include NVAX (Novavax Inc) at USD 10.27 with a 9.84% increase and 100% buy order activity on Pluang, CRSP (Crispr Therapeutics AG) at USD 57.27 with a 9.69% rise and 98% buy order activity, and ABCL (AbCellera Biologics Inc) at USD 12.73 with a 9.08% gain but a mixed 53% sell / 47% buy order split. Typical hold times range from 40 to 76 days.
Jefferies maintained a Hold rating on Kinder Morgan, lowering its price target from $35 to $33, which remains above the current stock price of $31.31. The company benefits from stable cash flows, with 96% secured by fee-based or hedged contracts, inc...
Several stocks saw sharp gains driven by key company developments. bioAffinity Technologies surged 63.55% after securing a Hong Kong patent for its lung cancer diagnostic technology, boosting its Asian market position. Antelope Enterprise Holdings ro...
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
